BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27236555)

  • 1. Synthetic Cystine-Knot Miniproteins - Valuable Scaffolds for Polypeptide Engineering.
    Avrutina O
    Adv Exp Med Biol; 2016; 917():121-44. PubMed ID: 27236555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical synthesis, backbone cyclization and oxidative folding of cystine-knot peptides: promising scaffolds for applications in drug design.
    Reinwarth M; Nasu D; Kolmar H; Avrutina O
    Molecules; 2012 Oct; 17(11):12533-52. PubMed ID: 23095896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural and engineered cystine knot miniproteins for diagnostic and therapeutic applications.
    Kolmar H
    Curr Pharm Des; 2011 Dec; 17(38):4329-36. PubMed ID: 22204431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystine-knot peptides: emerging tools for cancer imaging and therapy.
    Ackerman SE; Currier NV; Bergen JM; Cochran JR
    Expert Rev Proteomics; 2014 Oct; 11(5):561-72. PubMed ID: 25163524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering knottins as novel binding agents.
    Moore SJ; Cochran JR
    Methods Enzymol; 2012; 503():223-51. PubMed ID: 22230571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins.
    Kolmar H
    Curr Opin Pharmacol; 2009 Oct; 9(5):608-14. PubMed ID: 19523876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative binding proteins: biological activity and therapeutic potential of cystine-knot miniproteins.
    Kolmar H
    FEBS J; 2008 Jun; 275(11):2684-90. PubMed ID: 18435757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cystine knot motif in toxins and implications for drug design.
    Craik DJ; Daly NL; Waine C
    Toxicon; 2001 Jan; 39(1):43-60. PubMed ID: 10936622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragmentation follows structure: top-down mass spectrometry elucidates the topology of engineered cystine-knot miniproteins.
    Reinwarth M; Avrutina O; Fabritz S; Kolmar H
    PLoS One; 2014; 9(10):e108626. PubMed ID: 25303319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered knottin peptides as diagnostics, therapeutics, and drug delivery vehicles.
    Kintzing JR; Cochran JR
    Curr Opin Chem Biol; 2016 Oct; 34():143-150. PubMed ID: 27642714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative folding of peptides with cystine-knot architectures: kinetic studies and optimization of folding conditions.
    Reinwarth M; Glotzbach B; Tomaszowski M; Fabritz S; Avrutina O; Kolmar H
    Chembiochem; 2013 Jan; 14(1):137-46. PubMed ID: 23229141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial optimization of cystine-knot peptides towards high-affinity inhibitors of human matriptase-1.
    Glotzbach B; Reinwarth M; Weber N; Fabritz S; Tomaszowski M; Fittler H; Christmann A; Avrutina O; Kolmar H
    PLoS One; 2013; 8(10):e76956. PubMed ID: 24146945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the tumor vasculature with engineered cystine-knot miniproteins.
    Lui BG; Salomon N; Wüstehube-Lausch J; Daneschdar M; Schmoldt HU; Türeci Ö; Sahin U
    Nat Commun; 2020 Jan; 11(1):295. PubMed ID: 31941901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and MALDI-TOF Mass Spectrometric Characterization of a Novel Native and Recombinant Cystine Knot Miniprotein from Solanum tuberosum subsp. andigenum cv. Churqueña.
    Cotabarren J; Tellechea ME; Tanco SM; Lorenzo J; Garcia-Pardo J; Avilés FX; Obregón WD
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetically stabilized cystine knot peptides that bind alpha-v-beta-6 integrin with single-digit nanomolar affinities for detection of pancreatic cancer.
    Kimura RH; Teed R; Hackel BJ; Pysz MA; Chuang CZ; Sathirachinda A; Willmann JK; Gambhir SS
    Clin Cancer Res; 2012 Feb; 18(3):839-49. PubMed ID: 22173551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-stable peptide scaffolds for protein engineering-synthesis and folding of the circular cystine knotted cyclotide cycloviolacin O2.
    Leta Aboye T; Clark RJ; Craik DJ; Göransson U
    Chembiochem; 2008 Jan; 9(1):103-13. PubMed ID: 18058973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering agatoxin, a cystine-knot peptide from spider venom, as a molecular probe for in vivo tumor imaging.
    Moore SJ; Leung CL; Norton HK; Cochran JR
    PLoS One; 2013; 8(4):e60498. PubMed ID: 23573262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered cystine-knot miniproteins for diagnostic applications.
    Kolmar H
    Expert Rev Mol Diagn; 2010 Apr; 10(3):361-8. PubMed ID: 20370592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allotides: Proline-Rich Cystine Knot α-Amylase Inhibitors from Allamanda cathartica.
    Nguyen PQ; Luu TT; Bai Y; Nguyen GK; Pervushin K; Tam JP
    J Nat Prod; 2015 Apr; 78(4):695-704. PubMed ID: 25832441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered cystine knot miniproteins as potent inhibitors of human mast cell tryptase beta.
    Sommerhoff CP; Avrutina O; Schmoldt HU; Gabrijelcic-Geiger D; Diederichsen U; Kolmar H
    J Mol Biol; 2010 Jan; 395(1):167-75. PubMed ID: 19852971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.